FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
STRATIFYER Molecular Pathology GmbH
Industry / private company
Location:
Köln, Germany (DE)
ISNI
: -
Publications
(61)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
High androgen receptor mrna expression is associated with improved outcome in patients with high-risk non-muscle-invasive bladder cancer (2021)
Sikic D, Taubert H, Wirtz RM, Breyer J, Eckstein M, Weyerer V, Kubon J, et al.
Journal article
Krt20, krt5, esr1 and erbb2 expression can predict pathologic outcome in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer (2021)
Jütte H, Reike M, Wirtz RM, Kriegmair M, Erben P, Tully K, Weyerer V, et al.
Journal article
Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non–muscle-invasive Bladder Cancer: A Case Report (2021)
Weiß S, Hallmann S, Koch S, Eidt S, Stöhr R, Veltrup E, Roggisch J, et al.
Journal article
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer (2021)
Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, et al.
Journal article
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer (2021)
Sikic D, Eckstein M, Weyerer V, Kubon J, Breyer J, Roghmann F, Kunath F, et al.
Journal article
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy (2021)
Tully KH, Jütte H, Wirtz RM, Jarczyk J, Santiago-Walker A, Zengerling F, Breyer J, et al.
Journal article
Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder Cancer (2021)
Reiß J, Kälble S, Bründl J, Rosenhammer B, Gierth M, Weber F, Eckstein M, et al.
Journal article
Immunoprofiling in neuroendocrine neoplasms unveil immunosuppressive microenvironment (2020)
Busse A, Mochmann LH, Spenke C, Arsenic R, Briest F, Jöhrens K, Lammert H, et al.
Journal article
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer (2020)
Würfel FM, Wirtz RM, Winterhalter C, Taffurelli M, Santini D, Mandrioli A, Veltrup E, et al.
Journal article
Analysis of CXCL9, PD1 and PD-L1 mRNA in stage T1 non-muscle invasive bladder cancer and their association with prognosis (2020)
Kubon J, Sikic D, Eckstein M, Weyerer V, Stöhr R, Neumann A, Keck B, et al.
Journal article
‹
1
2
3
4
...
7
›